News Detail

Mumbai, 23 Nov 2022: The Indian Pharmacopoeia Commission (IPC) has rejected Central Drugs Standard Control Organisation (CDSCO)’s request for extension of timelines to implement Indian Pharmacopoeia (IP) 2022.
Drugs Controller General of India (DCGI) Dr VG Somani......
View Details
Source : Pharmabiz
Indian Pharmacopoeia Commission
IPC
CDSCO
Indian Pharmacopoeia
IP 2022
DCGI
phytopharmaceutical ingredient
Related News
- Counterfeiting of medical devices is a severe offense that jeopardizes human lives: Delhi HC (12-03-2025)
- Three Medicines claimed to cure ‘Urinary Stones’ and ‘Rheumatism’ seized in Telangana (12-03-2025)
- Voluntary recalls initiated after FDA testing of acne products for benzene (12-03-2025)
- NPPP, 2012 Lays down principles for regulation of drugs prices: Anupriya Patel in Rajya Sabha (12-03-2025)
- Health department orders to recall batch of ‘spurious Telma AM 40’ used for hypertension (12-03-2025)
- Zydus Life inks pact to acquire majority stake in Amplitude Surgical (12-03-2025)
- Steps taken to prioritize Research on Fungal Infections (12-03-2025)
- 1500 Pregabalin capsules seized from four places, four accused arrested (12-03-2025)
- India ranked 11th in global pharma exports in 2023: Anupriya Patel (12-03-2025)
- ED arrests 2 from Lucknow for shipping 'banned' drugs to US clients (12-03-2025)